Excitotoxicity and ALS: What is unique about the AMPA receptors expressed on spinal motor neurons?

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

Volumn 6, Issue 3, 2005, Pages 131-144

  Kawahara, Yukio ^a,b   Kwak, Shin ^b  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

ALS; AMPA receptor; Excitotoxicity; RNA editing

Indexed keywords

AMPA RECEPTOR; CALCIUM; CYCLOTHIAZIDE; ION CHANNEL; RECEPTOR SUBUNIT; REGULATOR PROTEIN;

ALTERNATIVE RNA SPLICING; AMYOTROPHIC LATERAL SCLEROSIS; CALCIUM TRANSPORT; CELL MEMBRANE PERMEABILITY; CELL SURFACE; DESENSITIZATION; EXCITOTOXICITY; HUMAN; MOLECULAR DYNAMICS; MOTONEURON; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; RECEPTOR DENSITY; REGULATORY MECHANISM; REVIEW; RNA EDITING; SYSTEMATIC REVIEW;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELL DEATH; HUMANS; MODELS, MOLECULAR; MOTOR NEURONS; NEUROTOXINS; RECEPTORS, AMPA; RNA EDITING; SPINAL CORD;

EID: 26444513243     PISSN: 14660822     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/14660820510037872     Document Type: Review

References (151)

1. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59-62.
2. Hadano S, Hand CK, Osuga H, et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet. 2001;29:166-73.
3. Yang Y, Hentati A, Deng HX, et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet. 2001;29:160-5.
4. Chen YZ, Bennett CL, Huynh HM, et al. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet. 2004;74:1128-35.
5. Nishimura AL, Mitne-Neto M, Silva HC, et al. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet. 2004;75:822-31.
6. Jackson M, Al-Chalabi A, Enayat ZE, Chioza B, Leigh PN, Morrison KE. Copper/zinc superoxide dismutase 1 and sporadic amyotrophic lateral sclerosis: analysis of 155 cases and identification of a novel insertion mutation. Ann Neurol. 1997;42:803-7.
7. Puls I, Jonnakuty C, LaMonte BH, et al. Mutant dynactin in motor neuron disease. Nat Genet. 2003;33:455-6.
8. Munch C, Sedlmeier R, Meyer T, et al. Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology. 2004;63:724-6.
9. Oosthuyse B, Moons L, Storkebaum E, et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet. 2001;28:131-8.
10. LaMonte BH, Wallace KE, Holloway BA, et al. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron. 2002;34:715-27.
11. Hafezparast M, Klocke R, Ruhrberg C, et al. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science. 2003;300:808-12.
12. Lambrechts D, Storkebaum E, Morimoto M, et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motor neurons against ischemic death. Nat Genet. 2003;34:383-94.
13. Ahmad-Annuar A, Shah P, Hafezparast M, et al. No association with common Caucasian genotypes in exons 8, 13 and 14 of the human cytoplasmic dynein heavy chain gene (DNCHC1) and familial motor neuron disorders. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4:150-7.
14. Kwak S, Kawahara Y. Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis. J Mol Med. 2005;83:110-20.
15. Furuyama T, Kiyama H, Sato K, et al. Region-specific expression of subunits of ionotropic glutamate receptors (AMPA-type, KA-type and NMDA receptors) in the rat spinal cord with special reference to nociception. Brain Res Mol Brain Res. 1993;18:141-51.
16. Tölle TR, Berthele A, Zieglgänsberger W, Seeburg PH, Wisden W. The differential expression of 16 NMDA and non-NMDA receptor subunits in the rat spinal cord and in periaqueductal gray. J Neurosci. 1993;13:5009-28.
17. Mennini T, Bigini P, Ravizza T, et al. Expression of glutamate receptor subtypes in the spinal cord of control and mnd mice, a model of motor neuron disorder. J Neurosci Res. 2002;70:553-60.
18. Allaoua H, Chaudieu I, Krieger C, Boksa P, Privat A, Quirion R. Alterations in spinal cord excitatory amino acid receptors in amyotrophic lateral sclerosis patients. Brain Res. 1992;579:169-72.
19. Choi DW. Excitotoxic cell death. J Neurobiol. 1992;23:1261-76.
20. Rothstein JD, Jin L, Dykes-Hoberg M, Kuncl RW. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sci. USA. 1993;90:6591-5.
21. Nakamura R, Kamakura K, Kwak S. Late-onset selective neuronal damage in the rat spinal cord induced by continuous intrathecal administration of AMPA. Brain Res. 1994;654:279-85.
22. Carriedo SG, Yin HZ, Weiss JH. Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J Neurosci. 1996;16:4069-79.
23. Hirata A, Nakamura R, Kwak S, Nagata N, Kamakura K. AMPA receptor-mediated slow neuronal death in the rat spinal cord induced by long-term blockade of glutamate transporters with THA. Brain Res. 1997;771:37-44.
24. 2+ dependent. Neuroreport. 1995;6:945-8.
25. 2+) overload and ROS generation in spinal motor neurons in vitro. J Neurosci. 2000;20:240-50.
26. 2+)-permeable AMPA receptors and selective vulnerability of motor neurons. J Neurol Sci. 2000;180:29-34.
27. van Den Bosch L, Robberecht W. Different receptors mediate motor neuron death induced by short and long exposures to excitotoxicity. Brain Res Bull. 2000;53:383-8.
28. van Den Bosch L, Schwaller B, Vleminckx V, et al. Protective effect of parvalbumin on excitotoxic motor neuron death. Exp Neurol. 2002;174:150-61.
29. Roy J, Minotti S, Dong L, Figlewicz DA, Durham HD. Glutamate potentiates the toxicity of mutant Cu/Zn-superoxide dismutase in motor neurons by postsynaptic calcium-dependent mechanisms. J Neurosci. 1998;18: 9673-84.
30. Hugon J, Vallat JM, Spencer PS, Leboutet MJ, Barthe D. Kainic acid induces early and delayed degenerative neuronal changes in rat spinal cord. Neurosci Lett. 1989;104:258-62.
31. Ikonomidou C, Qin Qin Y, Labruyere J, Olney JW. Motor neuron degeneration induced by excitotoxin agonists has features in common with those seen in the SOD1 transgenic mouse model of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 1996;55:211-24.
32. Sun H, Kawahara Y, Ito K, Kanazawa I, Tsuji S, Kwak S. Selective death of rat spinal motor neurons in vivo by intrathecal kainate infusion: an ALS model by AMPA receptor-mediated excitotoxicity. Amyotroph Lateral Scler Other Motor Neuron Disord. 5 (Suppl 2), 90.
33. 2+-dependent AMPA receptor-mediated motor neuron death. J Neurosci. 2003;23:4942-50.
34. Couratier P, Hugon J, Sindou P, Vallat JM, Dumas M. Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA/kainate receptors. Lancet. 1993;341:265-8.
35. Rothstein J, Tsai G, Kuncl R, et al. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol. 1990;28:18-25.
36. Wo ZG, Oswald RE. Unraveling the modular design of glutamate-gated ion channels. Trends Neurosci. 1995;18:161-8.
37. Passafaro M, Nakagawa T, Sala C, Sheng M. Induction of dendritic spines by an extracellular domain of AMPA receptor subunit GluR2. Nature. 2003;424:677-81.
38. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science. 1991;252:851-3.
39. Verdoorn T, Burnashev N, Monye RH, Seeburg P, Sakmann B. Structural determinants of ion flow through recombinant glutamate receptor channels. Science. 1991;252:1715-8.
40. Burnashev N, Khodorova A, Jonas P, et al. Calcium-permeable AMPA-kainate receptors in fusiform cerebellar glial cells. Science. 1992;256:1566-70.
41. 2+)-permeable AMPA receptors in rat brain by intracellular polyamines generates double rectification. J Physiol. 1995;486:305-12.
42. Lambolez B, Audinat E, Bochet P, Crepel F, Rossier J. AMPA receptor subunits expressed by single Purkinje cells. Neuron. 1992;9:247-58.
43. 2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS. Neuron. ;15:193-204.
44. Burnashev N, Monyer H, Seeburg P, Sakmann B. Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron. 1992;8:189-98.
45. Sommer B, Köhler M, Sprengel R, Seeberg P. RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell. 1991;67:11-9.
46. Kim U, Garner TL, Sanford T, Speicher D, Murray JM, Nishikura K. Purification and characterization of double-stranded RNA adenosine deaminase from bovine nuclear extracts. J Biol Chem. 1994;269:13480-9.
47. Melcher T, Maas S, Herb A, Sprengel R, Seeburg P, Higuchi M.1996 A mammalian RNA editing enzyme. Nature, 460-4.
48. Nutt S, Kamboj R. Differential RNA editing efficiency of AMPA receptor subunit GluR-2 in human brain. Neuroreport. 1994;5:1679-83.
49. Paschen W, Djuricic B. Regional differences in the extent of RNA editing of the glutamate receptor subunits GluR2 and GluR6 in rat brain. J Neurosci Meth. 1995;56:21-9.
50. Carlson NG, Howard J, Gahring LC, Rogers SW. RNA editing (Q/R site) and flop/flip splicing of AMPA receptor transcripts in young and old brains. Neurobiol Aging. 2000;21:599-606.
51. Kawahara Y, Ito K, Sun H, Kanazawa I, Kwak S. Low editing efficiency of GluR2 mRNA is associated with a low relative abundance of ADAR2 mRNA in white matter of normal human brain. Eur J Neurosci. 2003;18:23-33.
52. Kawahara Y, Ito K, Sun H, Ito M, Kanazawa I, Kwak S. Regulation of glutamate receptor RNA editing and ADAR mRNA expression in developing human normal and Down's syndrome brains. Brain Res Dev Brain Res. 2004; 148:151-5.
53. Kawahara Y, Ito K, Sun H, Aizawa H, Kanazawa I, Kwak S. Glutamate receptors: RNA editing and death of motor neurons. Nature. 2004;427:801.
54. Wang Q, Khillan J, Gadue P, Nishikura K. Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. Science. 2000;290:1765-8.
55. Higuchi M, Maas S, Single F, et al. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature. 2000;406:78-81.
56. Hume RI, Dingledine R, Heinemann SF, et al. Identification of a site in glutamate receptor subunits that controls calcium permeability. Science. 1991;253:1028-31.
57. Burnashev N, Zhou Z, Neher E, Sakmann B. Fractional calcium currents through recombinant GluR channels of the NMDA, AMPA and kainate receptor subtypes. J Physiol. 1995;485:403-18.
58. Kuner T, Beck C, Sakmann B, Seeburg PH, et al. Channel-lining residues of the AMPA receptor M2 segment: structural environment of the Q/R site and identification of the selectivity filter. J Neurosci. 2001;21:4162-72.
59. Sommer B, Keinänen K, Verdoorn TA, et al. Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS. Science. 1990;249:1580-5.
60. Lambolez B, Ropert N, Perrais D, Rossier J, Hestrin S. Correlation between kinetics and RNA splicing of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in neocortical neurons. Proc Natl Acad Sci. USA. 1996;93:1797-1802.
61. Mosbacher J, Schoepfer R, Monyer H, Burnashev N, Seeburg PH, Ruppersberg JP. A molecular determinant for submillisecond desensitization in glutamate receptors. Science. 1994;266:1059-62.
62. Lomeli H, Mosbacher J, Melcher T, et al. Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. Science. 1994;266:1709-13.
63. Brorson JR, Manzolillo PA, Gibbons SJ, Miller RJ. AMPA receptor desensitization predicts the selective vulnerability of cerebellar Purkinje cells to excitotoxicity. J Neurosci. 1995;15:4515-24.
64. Tomiyama M, Rodriguez-Puertas R, Cortes R, et al. Differential regional distribution of AMPA receptor subunit messenger RNAs in the human spinal cord as visualized by in situ hybridization. Neuroscience, 901-15.
65. Kawahara Y, Ito K, Sun H, Ito M, Kanazawa I, Kwak S. GluR4c, an alternative splicing isoform of GluR4, is abundantly expressed in the adult human brain. Brain Res Mol Brain Res. 2004;127:150-5.
66. Köhler M, Kornau HC, Seeburg PH. The organization of the gene for the functionally dominant alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor subunit GluR-B. J Biol Chem. 1994;269:17367-70.
67. Kolleker A, Zhu JJ, Schupp BJ, et al. Glutamatergic plasticity by synaptic delivery of GluR-B(long)-containing AMPA receptors. Neuron. 2003;40:1199-1212.
68. Gallo V, Upson LM, Hayes WP, Vyklicky L, Winters CA, Buonanno A. Molecular cloning and development analysis of a new glutamate receptor subunit isoform in cerebellum. J Neurosci. 1992;12:1010-23.
69. Zhu JJ, Esteban JA, Hayashi Y, Malinow R. Postnatal synaptic potentiation: delivery of GluR4-containing AMPA receptors by spontaneous activity. Nat Neurosci. 2000;3:1098-1106.
70. Wenthold RJ, Petralia RS, Blahos J, Niedzielski AS. Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons. J Neurosci. 1996; 16:1982-9.
71. Hayashi Y, Shi SH, Esteban JA, Piccini A, Poncer JC, Malinow R. Driving AMPA receptors into synapses by LTP and CaMKII: requirement for GluR1 and PDZ domain interaction. Science. 2000;287:2262-7.
72. Shi S, Hayashi Y, Esteban JA, Malinow R. Subunit-specific rules governing AMPA receptor trafficking to synapses in hippocampal pyramidal neurons. Cell. 2001;105:331-43.
73. Passafaro M, Piech V, Sheng M. Subunit-specific temporal and spatial patterns of AMPA receptor exocytosis in hippocampal neurons. Nat Neurosci. 2001;4:917-26.
74. Malinow R, Malenka RC. AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci. 2002;25:103-26.
75. Leonard AS, Davare MA, Horne MC, Garner CC, Hell JW. SAP97 is associated with the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor GluR1 subunit. J Biol Chem. 1998;273:19518-24.
76. Dev KK, Nishimune A, Henley JM, Nakanishi S. The protein kinase C alpha binding protein PICK1 interacts with short but not long form alternative splice variants of AMPA receptor subunits. Neuropharmacology. 1999;38:635-44.
77. Dong H, O'Brien RJ, Fung ET, Lanahan AA, Worley PF, Huganir RL. GRIP: a synaptic PDZ domain-containing protein that interacts with AMPA receptors. Nature. 1997;386:279-84.
78. Dong H, Zhang P, Liao D, Huganir RL. Characterization, expression, and distribution of GRIP protein. Ann N Y Acad Sci. 1999;868:535-40.
79. Osten P, Khatri L, Perez JL, et al. Mutagenesis reveals a role for ABP/GRIP binding to GluR2 in synaptic surface accumulation of the AMPA receptor. Neuron. 2000;27:313-25.
80. Perez JL, Khatri L, Chang C, Srivastava S, Osten P, Ziff EB. PICK1 targets activated protein kinase Calpha to AMPA receptor clusters in spines of hippocampal neurons and reduces surface levels of the AMPA-type glutamate receptor subunit 2. J Neurosci. 2001;21:5417-28.
81. Osten P, Srivastava S, Inman GJ, et al. The AMPA receptor GluR2 C terminus can mediate a reversible, ATP-dependent interaction with NSF and alpha- and beta-SNAPs. Neuron. 1998;21:99-110.
82. Song I, Kamboj S, Xia J, Dong H, Liao D, Huganir RL. Interaction of the N-ethylmaleimide-sensitive factor with AMPA receptors. Neuron. 1998;21:393-400.
83. Noel J, Ralph GS, Pickard L, et al. Surface expression of AMPA receptors in hippocampal neurons is regulated by an NSF-dependent mechanism. Neuron. 1999;23:365-76.
84. Luthi A, Chittajallu R, Duprat F, et al. Hippocampal LTD expression involves a pool of AMPARs regulated by the NSF-GluR2 interaction. Neuron. 1999;24:389-99.
85. Shen L, Liang F, Walensky LD, Huganir RL. Regulation of AMPA receptor GluR1 subunit surface expression by a 4. 1N-linked actin cytoskeletal association. J Neurosci. 2000;20:7932-40.
86. Coleman SK, Cai C, Mottershead DG, Haapalahti JP, Keinänen K. Surface expression of GluR-D AMPA receptor is dependent on an interaction between its C-terminal domain and a 4.1 protein. J Neurosci. 2003;23:798-806.
87. Chen L, Chetkovich DM, Petralia RS, et al. Stargazin regulates synaptic targeting of AMPA receptors by two distinct mechanisms. Nature. 2000;408:936-43.
88. Schnell E, Sizemore M, Karimzadegan S, Chen L, Bredt DS, Nicoll RA. Direct interactions between PSD-95 and stargazin control synaptic AMPA receptor number. Proc Natl Acad Sci. USA. 2002;99:13902-7.
89. Tomita S, Fukata M, Nicoll RA, Bredt DS. Dynamic interaction of stargazin-like TARPs with cycling AMPA receptors at synapses. Science. 2004;303:1508-11.
90. Carvalho AL, Kameyama K, Huganir RL. Characterization of phosphorylation sites on the glutamate receptor 4 subunit of the AMPA receptors. J Neurosci. 1999;19:4748-54.
91. Esteban JA, Shi SH, Wilson C, Nuriya M, Huganir RL, Malinow R. PKA phosphorylation of AMPA receptor subunits controls synaptic trafficking underlying plasticity. Nat Neurosci. 2003;6:136-43.
92. O'Brien R, Xu D, Mi R, Tang X, Hopf C, Worley P. Synaptically targeted Narp plays an essential role in the aggregation of AMPA receptors at excitatory synapses in cultured spinal neurons. J Neurosci. 2002;22:4487-98.
93. Brorson JR, Li D, Suzuki T. Selective expression of heteromeric AMPA receptors driven by flip-flop differences. J Neurosci. 2004;24:3461-70.
94. Greger IH, Khatri L, Ziff EB. RNA editing at arg607 controls AMPA receptor exit from the endoplasmic reticulum. Neuron. 2002;34:759-72.
95. Greger IH, Khatri L, Kong X, Ziff EB. AMPA receptor tetramerization is mediated by Q/R editing. Neuron. 2003;40:763-74.
96. Sans N, Vissel B, Petralia RS, et al. Aberrant formation of glutamate receptor complexes in hippocampal neurons of mice lacking the GluR2 AMPA receptor subunit. J Neurosci. 2003;23:9367-73.
97. 2+ influx underlies potent induction of injury. J Neurosci. 1996;16:5457-65.
98. 2+)-permeable AMPA receptors in neurological disorders. Trends Neurosci. 1997;20:464-70.
99. Pellegrini-Giampietro D, Zukin R, Bennett M, Cho S, Pulsinelli W. Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats. Proc Natl Acad Sci. USA. 1992;89:10499-503.
100. Pellegrini-Giampietro DE, Pulsinelli WA, Zukin RS. NMDA and non-NMDA receptor gene expression following global brain ischemia in rats: effect of NMDA and non-NMDA receptor antagonists. J Neurochem. 1994;62: 1067-73.
101. 2+ influx in hippocampal CA1 neurons of gerbil. J Neurosci. 1997;17:6179-88.
102. Pollard H, Heron A, Moreau J, Ben-Ari Y, Khrestchatisky M. Alterations of the GluR-B AMPA receptor subunit flip/flop expression in kainate-induced epilepsy and ischemia. Neuroscience. 1993;57:545-54.
103. A receptor gene expression in adult rat hippocampus: an in situ hybridization study. J Neurosci. 1994; 14:2697-707.
104. Jia Z, Agopyan N, Miu P, et al. Enhanced LTP in mice deficient in the AMPA receptor GluR2. Neuron. 1996;17:945-56.
105. Meng Y, Zhang Y, Jia Z. Synaptic transmission and plasticity in the absence of AMPA glutamate receptor GluR2 and GluR3. Neuron. 2003;39:163-76.
106. Iihara K, Joo DT, Henderson J, et al. The influence of glutamate receptor 2 expression on excitotoxicity in GluR2 null mutant mice. J Neurosci. 2001;21:2224-39.
107. 2+)-permeable AMPA receptor channels primes cell death in transient forebrain ischemia. Neuron. 2004;43:43-55.
108. 2+-permeable AMPA receptor promotes delayed cell death of hippocampal CA1 neurons following transient forebrain ischemia. Neurosci Res. 2003;46:41-51.
109. Kask K, Zamanillo D, Rozov A, Burnashev N, Sprengel R, Seeburg PH. The AMPA receptor subunit GluR-B in its Q/R site-unedited form is not essential for brain development and function. Proc Natl Acad Sci. USA. 1998;95:13777-82.
110. Seeburg PH, Single F, Kuner T, Higuchi M, Sprengel R. Genetic manipulation of key determinants of ion flow in glutamate receptor channels in the mouse. Brain Res. 2001;907:233-43.
111. Brusa R, Zimmermann F, Koh D, et al. Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice. Science. 1995;270:1677-80.
112. Feldmeyer D, Kask K, Brusa R, et al. Neurological dysfunctions in mice expressing different levels of the Q/R site-unedited AMPAR subunit GluR-B. Nat Neurosci. 1999;2:57-64.
113. Kamphuis W, Lopes da Silva F. Editing status at the Q/R site of glutamate receptor-A, -B, -5 and -6 subunit mRNA in the hippocampal kindling model of epilepsy. Brain Res Mol Brain Res. 1995;29:35-42.
114. Kamphuis W, de Leeuw F, Lopes da Silva F. Ischemia does not alter the editing status at the Q/R site of glutamate receptor-A, -B, -5 and -6 subunit mRNA. Neuroreport. 1995;6:1133-6.
115. Paschen W, Schmitt J A, Uto A. RNA editing of glutamate receptor subunits GluR2, GluR5 and GluR6 in transient cerebral ischemia in the rat. J Cereb Blood Flow Metab. 1996;16:548-56.
116. Akbarian S, Smith M, Jones E. Editing for an AMPA receptor subunit RNA in prefrontal cortex and striatum in Alzheimer's disease, Huntington's disease and schizophrenia. Brain Res. 1995;699:297-304.
117. Paschen W, Hedreen J, Ross C. RNA editing of the glutamate receptor subunits GluR2 and GluR6 in human brain tissue. J Neurochem. 1994;63:1596-1602.
118. Grigorenko EV, Bell WL, Glazier S, Pons T, Deadwyler S. Editing status at the Q/R site of the GluR2 and GluR6 glutamate receptor subunits in the surgically excised hippocampus of patients with refractory epilepsy. Neuroreport. 1998;9:2219-24.
119. Kortenbruck G, Berger E, Speckmann EJ, Musshoff U. RNA editing at the Q/R site for the glutamate receptor subunits GLUR2, GLUR5, and GLUR6 in hippocampus and temporal cortex from epileptic patients. Neurobiol Dis. 2001;8:459-68.
120. Takuma H, Kwak S, Yoshizawa T, Kanazawa I. Reduction of GluR2 RNA editing, a molecular change that increases calcium influx through AMPA receptors, selective in the spinal ventral gray of patients with amyotrophic lateral sclerosis. Ann Neurol. 1999;46:806-15.
121. Zorumski CF, Thio LL, Clark GD, Clifford DB. Blockade of desensitization augments quisqualate excitotoxicity in hippocampal neurons. Neuron. 1990;5:61-6.
122. Ballerini L, Bracci E, Nistri A. Desensitization of AMPA receptors limits the amplitude of EPSPs and the excitability of motor neurons of the rat isolated spinal cord. Eur J Neurosci. 1995;7:1229-34.
123. Vollmar W, Gloger J, Berger E, et al. RNA editing (R/G site) and flip-flop splicing of the AMPA receptor subunit GluR2 in nervous tissue of epilepsy patients. Neurobiol Dis. 2004;15:371-9.
124. van Damme P, van Den Bosch L, van Houtte E, Callewaert G, Robberecht W. GluR2-dependent properties of AMPA receptors determine the selective vulnerability of motor neurons to excitotoxicity. J Neurophysiol. 2002;88:1279-87.
125. Vandenberghe W, Robberecht W, Brorson J. AMPA receptor calcium permeability, GluR2 expression, and selective motor neuron vulnerability. J Neurosci. 2000;20:123-32.
126. Greig A, Donevan SD, Mujtaba TJ, Parks TN, Rao MS. Characterization of the AMPA-activated receptors present on motor neurons. J Neurochem. 2000;74:179-91.
127. Virgo L, Samarasinghe S, de Belleroche J. Analysis of AMPA receptor subunit mRNA expression in control and ALS spinal cord. Neuroreport. 1996;7:2507-11.
128. Pellegrini-Giampietro DE, Fan S, Ault B, Miller BE, Zukin RS. Glutamate receptor gene expression in spinal cord of arthritic rats. J Neurosci. 1994;14:1576-83.
129. Jakowec MW, Fox AJ, Martin LJ, Kalb RG. Quantitative and qualitative changes in AMPA receptor expression during spinal cord development. Neuroscience. 1995;67:893-907.
130. Grossman SD, Wolfe BB, Yasuda RP, Wrathall JR. Alterations in AMPA receptor subunit expression after experimental spinal cord contusion injury. J Neurosci. 1999;19:5711-20.
131. Laslo P, Lipski J, Nicholson LF, Miles GB, Funk GD. GluR2 AMPA receptor subunit expression in motor neurons at low and high risk for degeneration in amyotrophic lateral sclerosis. Exp Neurol. 2001;169:461-71.
132. Nagy GG, Al-Ayyan M, Andrew D, Fukaya M, Watanabe M, Todd AJ. Widespread expression of the AMPA receptor GluR2 subunit at glutamatergic synapses in the rat spinal cord and phosphorylation of GluR1 in response to noxious stimulation revealed with an antigen-unmasking method. J Neurosci. 2004;24:5766-77.
133. Williams T, Day N, Ince P, Kamboj R, Shaw P. Calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors: a molecular determinant of selective vulnerability in amyotrophic lateral sclerosis. Ann Neurol. 1997;42:200-7.
134. Shaw PJ, Williams TL, Slade JY, Eggert CJ, Ince PG. Low expression of GluR2 AMPA receptor subunit protein by human motor neurons. Neuroreport. 1999;10:261-5.
135. Bar-Peled O, O'Brien RJ, Morrison JH, Rothstein JD. Cultured motor neurons possess calcium-permeable AMPA/kainate receptors. Neuroreport. 1999;10:855-9.
136. 2+) permeation of AMPA receptors in cerebellar neurons expressing glu receptor 2. J Neurosci. 1999;19:9149-59.
137. 2+ permeability of AMPA-type glutamate receptor channels in neocortical neurons caused by differential GluR-B subunit expression. Neuron. 1994;12:1281-9.
138. Tsuzuki K, Lambolez B, Rossier J, Ozawa S. Absolute quantification of AMPA receptor subunit mRNAs in single hippocampal neurons. J Neurochem. 2001;77:1650-9.
139. Spalloni A, Albo F, Ferrari F, et al. Cu/Zn-superoxide dismutase (GLY93->ALA) mutation alters AMPA receptor subunit expression and function and potentiates kainate-mediated toxicity in motor neurons in culture. Neurobiol Dis. 2004;15:340-50.
140. Dai WM, Egebjerg J, Lambert JD. Characteristics of AMPA receptor-mediated responses of cultured cortical and spinal cord neurons and their correlation to the expression of glutamate receptor subunits, GluR1-4. Br J Pharmacol. 2001;132:1859-75.
141. Kawahara Y, Kwak S, Sun H, et al. Human spinal motor neurons express low relative abundance of GluR2 mRNA: an implication for excitotoxicity in ALS. J Neurochem. 2003;85:680-9.
142. Heath PR, Tomkins J, Ince PG, Shaw PJ. Quantitative assessment of AMPA receptor mRNA in human spinal motor neurons isolated by laser capture microdissection. Neuroreport. 2002;13:1753-7.
143. Morrison BM, Janssen WG, Gordon JW, Morrison JH. Light and electron microscopic distribution of the AMPA receptor subunit, GluR2, in the spinal cord of control and G86R mutant superoxide dismutase transgenic mice. J Comp Neurol. 1998;395:523-34.
144. Pieri M, Gaetti C, Spalloni A, et al. Alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionate receptors in spinal cord motor neurons are altered in transgenic mice over-expressing human Cu/Zn superoxide dismutase (Gly93->A1a) mutation. Neuroscience. 2003;122:47-58.
145. Rembach A, Turner BJ, Bruce S, et al. Antisense peptide nucleic acid targeting GluR3 delays disease onset and progression in the SOD1 G93A mouse model of familial ALS. J Neurosci Res. 2004;77:573-82.
146. Tateno M, Sadakata H, Tanaka M, et al. Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model. Hum Mol Genet. 2004;13:2183-96.
147. Suzuki T, Tsuzuki K, Kameyama K, Kwak S. Recent advances in the study of AMPA receptors. Nippon Yakurigaku Zasshi. 2003;122:515-26.
148. Tomiyama M, Rodriguez-Puertas R, Cortes R, Pazos A, Palacios JM, Mengod G. Flip and flop splice variants of AMPA receptor subunits in the spinal cord of amyotrophic lateral sclerosis. Synapse. 2002;45:245-9.
149. Vandenberghe W, Ihle EC, Patneau DK, Robberecht W, Brorson JR. AMPA receptor current density, not desensitization, predicts selective motor neuron vulnerability. J Neurosci. 2000;20:7158-66.
150. Garry EM, Moss A, Rosie R, Delaney A, Mitchell R, Fleetwood-Walker SM. Specific involvement in neuropathic pain of AMPA receptors and adapter proteins for the GluR2 subunit. Mol Cell Neurosci. 2003;24:10-22.
151. Inglis FM, Crockett R, Korada S, Abraham WC, Hollmann M, Kalb RG. The AMPA receptor subunit GluR1 regulates dendritic architecture of motor neurons. J Neurosci. 2002;22:8042-51.